{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:40:09Z","timestamp":1739986809142,"version":"3.37.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1124\/jpet.113.203729","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T04:43:36Z","timestamp":1363841016000},"page":"342-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Behavioral Effects and Pharmacokinetics of (\u00b1)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons"],"prefix":"10.1016","volume":"345","author":[{"given":"Amy K.","family":"Goodwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney D.","family":"Shell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Ricaurte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Ator","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1993","series-title":"Principles of Neurology","author":"Adams","key":"10.1124\/jpet.113.203729_bib1"},{"key":"10.1124\/jpet.113.203729_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.109.158303","article-title":"Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2\/3 subtypes","volume":"332","author":"Ator","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203729_bib3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1124\/dmd.109.028506","article-title":"Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat","volume":"37","author":"Baumann","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.113.203729_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1360-0443.2006.01423.x","article-title":"A review of the acute subjective effects of MDMA\/ecstasy","volume":"101","author":"Baylen","year":"2006","journal-title":"Addiction"},{"key":"10.1124\/jpet.113.203729_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0269881108097631","article-title":"Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use","volume":"24","author":"Bedi","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.fpc.0000230419.05221.fc","article-title":"Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (\u2018Ecstasy\u2019) cytotoxicity","volume":"16","author":"Carmo","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.113.203729_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0149-7634(03)00031-9","article-title":"The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)","volume":"27","author":"Cole","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.113.203729_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pbb.2007.03.015","article-title":"Oral administration of (+\/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques","volume":"87","author":"Crean","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.113.203729_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans","volume":"49","author":"de la Torre","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.113.203729_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","article-title":"Pharmacology of MDMA in humans","volume":"914","author":"de la Torre","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.113.203729_bib11","series-title":"Psychotherapeutic Drugs, Part 1","first-page":"175","article-title":"Interspecies differences in drug effects: behavioral","author":"Dews","year":"1976"},{"key":"10.1124\/jpet.113.203729_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881108099214","article-title":"Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers","volume":"24","author":"Dumont","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.genhosppsych.2007.09.007","article-title":"Serotonin syndrome: a complex but easily avoidable condition","volume":"30","author":"Dvir","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1124\/jpet.113.203729_bib14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/0269881109354926","article-title":"The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users","volume":"24","author":"Fagundo","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","article-title":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","volume":"173","author":"Farr\u00e9","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.203729_bib16","first-page":"101","article-title":"Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs","volume":"94","author":"Gold","year":"1989","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/jpet.113.203729_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-009-1477-8","article-title":"Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons","volume":"204","author":"Goodwin","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.203729_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.113.203729_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng0298-155","article-title":"Evolutionary sequence comparisons using high-density oligonucleotide arrays","volume":"18","author":"Hacia","year":"1998","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.113.203729_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfq374","article-title":"Genetic polymorphism and toxicology\u2014with emphasis on cytochrome p450","volume":"120","author":"Johansson","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.113.203729_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/FTD.0b013e3181684fa0","article-title":"Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults","volume":"30","author":"Kolbrich","year":"2008","journal-title":"Ther Drug Monit"},{"issue":"Suppl 2","key":"10.1124\/jpet.113.203729_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2007-979349","article-title":"Chemistry and pharmacology of hallucinogens, entactogens and stimulants","volume":"31","author":"Kovar","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/jpet.113.203729_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drugalcdep.2011.03.030","article-title":"Understanding subtypes of inner-city drug users with a latent class approach","volume":"118","author":"Kuramoto","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.113.203729_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0091-3057(82)90366-5","article-title":"A tethering system for intravenous and intragastric drug administration in the baboon","volume":"17","author":"Lukas","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.113.203729_bib25","unstructured":"Malberg JE, Bonson KR (2001) How MDMA works in the brain, in Ecstasy: The Complete Guide (Holland J, ed), Park Street Press, Rochester, Vermont."},{"key":"10.1124\/jpet.113.203729_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300808","article-title":"Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons","volume":"31","author":"Mechan","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.113.203729_bib27","series-title":"Toxicokinetics and New Drug Development","first-page":"42","article-title":"The use of interspecies scaling in toxicokinetics","author":"Mordenti","year":"1989"},{"key":"10.1124\/jpet.113.203729_bib28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.2011.03399.x","article-title":"Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational \u2018ecstasy\u2019 users","volume":"106","author":"Morefield","year":"2011","journal-title":"Addiction"},{"key":"10.1124\/jpet.113.203729_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.111.180612","article-title":"Metabolism and disposition of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) in baboons after oral administration: comparison with humans reveals marked differences","volume":"338","author":"Mueller","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203729_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/FTD.0b013e3181a4f6c2","article-title":"Direct comparison of (+\/-) 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) disposition and metabolism in squirrel monkeys and humans","volume":"31","author":"Mueller","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.113.203729_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.forsciint.2008.12.002","volume":"184","author":"Mueller","year":"2009","journal-title":"Forensic Sci Int"},{"key":"10.1124\/jpet.113.203729_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.108.141366","article-title":"Nonlinear pharmacokinetics of (+\/-)3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses","volume":"327","author":"Mueller","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203729_bib33","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1124\/dmd.109.028340","article-title":"Further studies on the role of metabolites in (+\/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity","volume":"37","author":"Mueller","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.113.203729_bib34","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0024-3205(01)01373-X","article-title":"Effects of repeated doses of MDMA (\u201cecstasy\u201d) on cell-mediated immune response in humans","volume":"69","author":"Pacifici","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.203729_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881105048900","article-title":"Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy","volume":"19","author":"Parrott","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00213-012-2894-7","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart","volume":"225","author":"Peir\u00f3","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.203729_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0269881105058777","article-title":"Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study","volume":"20","author":"Rodgers","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/14740338.4.1.91","article-title":"Drug-induced movement disorders in children and adolescents","volume":"4","author":"Rodnitzky","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/jpet.113.203729_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/138920110791591490","article-title":"Neurotoxicity of ecstasy (MDMA): an overview","volume":"11","author":"Sarkar","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1124\/jpet.113.203729_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/anatox\/35.7.470","article-title":"(\u00b1)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice","volume":"35","author":"Scheidweiler","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.113.203729_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.euroneuro.2008.10.004","article-title":"The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene","volume":"19","author":"Schilt","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"year":"1960","series-title":"Tactics of Scientific Research","author":"Sidman","key":"10.1124\/jpet.113.203729_bib42"},{"key":"10.1124\/jpet.113.203729_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1369-1600.2010.00276.x","article-title":"An integrated genome research network for studying the genetics of alcohol addiction","volume":"15","author":"Spanagel","year":"2010","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.113.203729_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-001-0995-9","article-title":"Sub-acute effects of MDMA (+\/-3,4-methylenedioxymethamphetamine, \u201cecstasy\u201d) on mood: evidence of gender differences","volume":"161","author":"Verheyden","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.203729_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881107083639","article-title":"MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine\/norepinephrine transport inhibitor","volume":"22","author":"Verrico","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3565(24)37370-7","article-title":"Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons","volume":"285","author":"Weerts","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203729_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/1064-1297.15.4.309","article-title":"The value of nonhuman primates in drug abuse research","volume":"15","author":"Weerts","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.113.203729_bib48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/emj.2010.092270","article-title":"Variability in the 3,4-methylenedioxymethamphetamine content of \u2018ecstasy\u2019 tablets in the UK","volume":"28","author":"Wood","year":"2011","journal-title":"Emerg Med J"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418603X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418603X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.203729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:21:53Z","timestamp":1739985713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418603X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S002235652418603X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.203729","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral Effects and Pharmacokinetics of (\u00b1)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.203729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}